Your browser doesn't support javascript.
loading
Effectiveness and safety of rivaroxaban versus warfarin among nonvalvular atrial fibrillation patients with obesity and diabetes.
Weir, Matthew R; Chen, Yen-Wen; He, Jinghua; Bookhart, Brahim; Campbell, Alicia; Ashton, Veronica.
Afiliação
  • Weir MR; University of Maryland School of Medicine, Baltimore, MD, USA. Electronic address: Mweir@som.umaryland.edu.
  • Chen YW; Janssen Scientific Affairs, LLC, Titusville, NJ, USA. Electronic address: ychen342@its.jnj.com.
  • He J; Janssen Scientific Affairs, LLC, Titusville, NJ, USA. Electronic address: jhe31@its.jnj.com.
  • Bookhart B; Janssen Scientific Affairs, LLC, Titusville, NJ, USA. Electronic address: bbookhar@its.jnj.com.
  • Campbell A; Janssen Scientific Affairs, LLC, Titusville, NJ, USA. Electronic address: acampb17@its.jnj.com.
  • Ashton V; Janssen Scientific Affairs, LLC, Titusville, NJ, USA. Electronic address: vashton1@its.jnj.com.
J Diabetes Complications ; 35(11): 108029, 2021 11.
Article em En | MEDLINE | ID: mdl-34538715

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Varfarina / Diabetes Mellitus / Embolia / Rivaroxabana Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Diabetes Complications Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Varfarina / Diabetes Mellitus / Embolia / Rivaroxabana Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Diabetes Complications Ano de publicação: 2021 Tipo de documento: Article